PCSK9

Coral reef sea underwater
Biotech

Merck dives into data showing PCSK9 pill easily outswims rivals

Merck lifted the lid on the third positive phase 3 trial of its PCSK9 inhibitor, showing the edge the asset has over other oral non-statin therapies.
Nick Paul Taylor Mar 30, 2026 11:45am
Merck Co

Merck's PCSK9 drug mounts injectable-like cholesterol reductions

Nov 10, 2025 10:59am
Coral reef sea underwater

Merck's oral PCSK9 makes waves with 3rd phase 3 win

Sep 2, 2025 9:35am
heart cardiovascular check up stethescope

AZ's oral PCSK9 inhibitor halves bad cholesterol in phase 2

Mar 31, 2025 12:00pm
Graphic of someone in a boat navigating the rise and fall of different data riding data plots like a wave

Verve halts VERVE-101 enrollment, focuses on 2nd PCSK9 editor

Apr 2, 2024 7:00am
start line beginning road path starting point journey

Merck bets big on oral PCSK9 inhibitor with phase 3 program

Aug 25, 2023 8:35am